A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation. In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc. According to our (Global Info Research) latest study, the global Travelers Vaccines market size was valued at USD 3460.7 million in 2022 and is forecast to a readjusted size of USD 6095 million by 2029 with a CAGR of 8.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%. This report is a detailed and comprehensive analysis for global Travelers Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by End Users. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global Travelers Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2018-2029 Global Travelers Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2018-2029 Global Travelers Vaccines market size and forecasts, by Type and by End Users, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2018-2029 Global Travelers Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (USD/Dose), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Travelers Vaccines To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Travelers Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Sanofi Pasteur, Merck, Pfizer and CNBG, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market Segmentation Travelers Vaccines market is split by Type and by End Users. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End Users in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type Meningococcal Vaccine Japanese Encephalitis Vaccine Yellow Fever Vaccine Hepatitis Vaccine Cholera Vaccine Other Market segment by End Users Tourists Students Workers Others Major players covered GlaxoSmithKline Sanofi Pasteur Merck Pfizer CNBG Sanofi Pasteur MSD Serum Institute of India Biokangtai Market segment by region, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia) South America (Brazil, Argentina, Colombia, and Rest of South America) Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa) The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Travelers Vaccines product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top manufacturers of Travelers Vaccines, with price, sales, revenue and global market share of Travelers Vaccines from 2018 to 2023. Chapter 3, the Travelers Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Travelers Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029. Chapter 5 and 6, to segment the sales by Type and end users, with sales market share and growth rate by type, end users, from 2018 to 2029. Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Travelers Vaccines market forecast, by regions, type and end users, with sales and revenue, from 2024 to 2029. Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War. Chapter 13, the key raw materials and key suppliers, and industry chain of Travelers Vaccines. Chapter 14 and 15, to describe Travelers Vaccines sales channel, distributors, customers, research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of Travelers Vaccines 1.2 Market Estimation Caveats and Base Year 1.3 Market Analysis by Type 1.3.1 Overview: Global Travelers Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029 1.3.2 Meningococcal Vaccine 1.3.3 Japanese Encephalitis Vaccine 1.3.4 Yellow Fever Vaccine 1.3.5 Hepatitis
